Drug Delivery Market Analysis and Reports | USA Conference Series

Market Analysis - Drug Delivery 2017

Glance at Market of Drug Delivery:

The global advanced drug delivery market should grow from roughly $178.8 billion in 2015 to nearly $227.3 billion by 2020, with a compound annual growth rate (CAGR) of 4.9%. Analyses of global market trends, with data from 2013, estimates for 2015, and projections of compound annual growth rates (CAGRs) to 2020

For 2015, Drug Delivery Global market reached $150.3 billion, according to BCC research. This was an increase from $142 billion the previous year. Given its predicted annual growth the market represents a considerable business opportunity, which has been reflected in the increasing number of drug delivery specialists.

Figure 1: Drug Delivery Market worldwide (2013-15)

Figure 2: Worldwide Market (2015-2020)

Major Drug Delivery Associations around the Globe

  • Controlled Release Society
  • Society for biomaterials
  • Washington State Pharmacy Association
  • Inhalation Drug Delivery Association
  • International society of drug delivery sciences and technology.
  • American Association of Pharmaceutical Scientists
  • Japanese Society of Drug Delivery Systems
  • Parenteral Drug Association
  • International Association for Pharmaceutical Technology

Top Universities:

USA

  • Harvard University
  • Stanford University
  • University California
  • Massachusetts Inst Tech (MIT)
  • California Inst Tech
  • Princeton University
  • University Chicago
  • Yale University
  • Cornell University
  • University Pennsylvania

Global

  • University Oxford
  • Tokyo University
  • Kyoto University
  • Imperial College London
  • University British Columbia
  • Tech University Munich
  • University Paris 11
  • University Zurich

Top companies playing key roles in drug delivery

USA

  • Oncolytics Biotech
  • Bristol-Myers Squibb
  • GlaxoSmithKline
  • Bend Research
  • Pfizer
  • BioDelivery Sciences

Global

  • PolyActivaUnilife
  • Mati Therapeutics
  • Formac Pharmaceuticals
  • Battelle
  • Toxikon
  • Novartis

Target Audience:

Scientists, CEOs, CROs, Directors, Healthcare providers, Clinicians/Doctors, Investors, Marketing managers/retailers,Professors and Students from Academia in the study of Drug Delivery.

Topics involving Business Opportunities:

  • Smart Drug Delivery System
  • Nanotechnologies
  • Metabolomics
  • Proteomics
  • Transdermal drug delivery
  • Vaccine Drug Delivery
  • Bio therapeutics
  • Medical Devices for Drug Delivery
  • Neural drug delivery
  • Biopolymers, coatings and bio absorbable intelligent materials

Drug Delivery 2017 conveys recent developments in Novel Drug Delivery Systems (NDDS), approaches in drug delivery systems and Challenges

Carrier-mediated drug delivery has emerged as a powerful methodology for the treatment of various pathologies. The therapeutic index of traditional and novel drugs is enhanced via the increase of specificity due to targeting of drugs to a particular tissue, cell or intracellular compartment, the control over release kinetics, the protection of the active agent or a combination of the above. Nanoparticles (NPs) were proposed as drug carriers over 30 years ago and have received growing attention since, mainly due to their stability, enhanced loading capabilities and control over physicochemical properties. The unique pathophysiology of solid tumors allows passive accumulation of NPs at these sites upon intravenous injection. Furthermore, stealth NPs with long circulation times is more efficient in reaching tumor tissue.

The global advanced drug delivery market should grow from roughly $178.8 billion in 2015 to nearly $227.3 billion by 2020, with a compound annual growth rate (CAGR) of 4.9%.

Importance & Scope:

Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. This conference will discuss effective formulation and delivery technologies for enhancing solubility and drug delivery. Drug delivery 2017 aims to aggregate leading experts from around the world who will discuss on formulation and delivery, and show how they are developing poorly soluble drugs into scientifically sound, patient-centric formulations, and reducing their product development timelines. It also provides the chance for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the fields of Drug delivery.

Drug delivery 2017 will showcase new and innovative technologies by renowned scientists. It benefits to pharmacological, researchers, professors, and companies. Conferences also benefits and share knowledge between scientist, doctors and delegates. Exchange of idea among companies and they share knowledge to each other about their product at the conference leading to lead to Public- private partnerships and collaborations.  The university member attend conferences to know and share about what research has already been done and what research is going to be done in the area of drug delivery. We bring together business, creative, and technology leaders from the Drug Deliver industry for the most current and relevant.